Pidotimod is a synthetic dipeptide with immunological modulatory activity on both the adaptive and innate immune responses. This compound has been shown to induce dendritic cell maturation and up-regulate the expression of HLA-DR and co-stimulatory molecules CD83 and CD86, which are integral to communication with adaptive immunity cells. Pidotimod has also been shown to stimulate dendritic cells to release pro-inflammatory molecules such as MCP-1 and TNF-α cytokines, and to inhibit thymocyte apoptosis caused by a variety of apoptosis inducing molecules.
Pitidomod is mainly used in children with recurrent respiratory infections and urinary tract infections (urinary tract infections). It also has therapeutic effects on chronic bronchitis and viruses. Flu and viral herpes are effective. It can also be used for infections caused by Streptococcus pneumoniae and Escherichia coli, Green bacillus, Proteus.

Function
Pitidomod is mainly used in children with recurrent respiratory infections and urinary tract infections (urinary tract infections). It also has therapeutic effects on chronic bronchitis and viruses. Flu and viral herpes are effective. It can also be used for infections caused by Streptococcus pneumoniae and Escherichia coli, Green bacillus, Proteus.